ENTITY
SMARTSCORE: 3.2/5
Emergent Biosolutions

Emergent Biosolutions (EBS US)

5
Analysis
Health CareUnited States
Emergent BioSolutions, Inc. is a global specialty biopharmaceutical company. The Company develops, manufactures, and delivers a portfolio of medical countermeasures for biological and chemical threats as well as emerging infectious diseases. Emergent also develops and commercializes therapeutics and other specialty products for hospitals and clinics.
more
16 Mar 2025 00:30

APAC Healthcare Weekly (Mar 16)- Celltrion, Ono Pharma, Sun Pharma, Syngene, Zydus, Sichuan Kelun

APAC healthcare companies continued to get approvals for new products and initiates clinical trials. The companies continued with acquisitions and...

Logo
473 Views
Share
bullishS&P 500 INDEX
10 Feb 2021 02:34

U.S. Equity Strategy: Bullish Outlook Intact

The action we are seeing in broad indexes, Sectors, and in market dynamics continues to support our overall bullish outlook. Continue to buy dips.

Logo
280 Views
Share
bearishS&P 500 INDEX
19 May 2020 23:34

U.S. Equity Strategy: Round Trip Back To Resistance

Our base case continues to be for near-term consolidation while the market determines the implications of states’ reopening (i.e., the...

Logo
300 Views
Share
bullishS&P 500 INDEX
05 May 2020 19:02

U.S. Equities: Upside Momentum Lost, But Not Breaking Down

In today's report we highlight key levels and several metrics we are watching that will provide us clues as to where the S&P 500 is headed...

Logo
530 Views
Share
bearishS&P 500 INDEX
19 Mar 2020 11:56

S&P 500 Technical Appraisal and Support Levels

S&P 500 Potential Support Levels. Current logical support levels we are monitoring include the December 2018 low of 2,346 and prior resistance...

Logo
489 Views
Share
No more insights
x